IP Library › Assignment 020968/0832
Patent Assignment
Reel/Frame 020968/0832

Change of Name

Recorded: 2008-05-19 Pages: 2
Assignor
SCHERING AKTIENGESELLSCHAFT
Executed: 2006-12-29
Assignee
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
MULLERSTRABE 178, BERLIN, 13353, GERMANY
Covered Properties (2)
Haloalkyl Containing Compounds as Cysteine Protease Inhibitors
Patent: 8,013,186 →
Application: 11/791,928 →
Publication: US 2009/0023781
Sulfonamide Compounds as Cysteine Protease Inhibitors
Patent: 8,163,735 →
Application: 11/792,101 →
Publication: US 2009/0233909
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 19, 2008
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: CELERA GENOMICS GROUP
Reel/Frame 020967/0511 →
Assignment of Assignor's Interest May 19, 2008
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: CELERA GENOMICS GROUP
Reel/Frame 020967/0663 →
Assignment of Assignor's Interest May 29, 2008
From: CELERA GENOMICS GROUP
To: VIROBAY, INC.
Reel/Frame 021014/0825 →
Assignment of Assignor's Interest May 29, 2008
From: CELERA GENOMICS GROUP
To: VIROBAY, INC.
Reel/Frame 021014/0894 →
Assignment of Assignor's Interest Mar 11, 2016
From: VIROBAY, INC.
To: QUEST DIAGNOSTICS INVESTMENTS LLC
Reel/Frame 037959/0165 →